Primer: Brightgene Bio-Medical Technology (BBMT HK) - Aug 2026
Brightgene is a research-driven biopharmaceutical company transitioning from a focus on high-barrier generic drugs and Active Pharmaceutical...
94 Views
Pre-IPO Brightgene Bio-Medical Technology (A/H Listing) - 2025 Will Face a Performance Slump
Declining APIs business, VBP and high R&D costs may impact performance in 2025, but rebound expected in 2026 with potential contributions from...
253 Views
No more insights